All Photos(1)

W291501

Sigma-Aldrich

Polysorbate 20

CAS Number:
FEMA Number:
2915
MDL number:
E Number:
E 432
NACRES:
NA.21

Quality Level

grade

FG

reg. compliance

EU Regulation 1333/2008 & 178/2002
FDA 21 CFR 172.515
FDA 21 CFR 173.310
FDA 21 CFR 175.105
FDA 21 CFR 178.3400

description

Biological source: corn or palm

Documentation

see Safety & Documentation for available documents

Featured Industry

Flavors and Fragrances

Organoleptic

alcohol

food allergen

no known allergens

fragrance allergen

no known allergens

InChI

1S/C26H50O10/c1-2-3-4-5-6-7-8-9-10-11-24(30)34-19-18-31-20-22(32-15-12-27)26-25(35-17-14-29)23(21-36-26)33-16-13-28/h22-23,25-29H,2-21H2,1H3

InChI key

HMFKFHLTUCJZJO-UHFFFAOYSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Polysorbate 20 is a hydrophilic nonionic surfactant generally used as emulsifiers, dispersing agent and solubilizer.

Application

Polysorbate 20 has been used in a study to assess its potential as a generally recognized as safe (GRAS) plasticizer in imparting plasticity to carnauba wax.

Packaging

1 kg in poly bottle
10, 25 kg in poly drum

Storage Class Code

12 - Non Combustible Liquids

WGK

WGK 1

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US),Eyeshields,Gloves

CRC Handbook of Food, Drug, and Cosmetic Excipients, 295-296 (1992)
Plasticisation of carnauba wax with generally recognised as safe (GRAS) additives.
Zhang Y, et al.
Polymer, 86, 208-219 (2016)
Julie Beegle et al.
Stem cells (Dayton, Ohio), 33(6), 1818-1828 (2015-02-24)
Mesenchymal stem cells/multipotent stromal cells (MSCs) are promising therapeutics for a variety of conditions. However, after transplantation, cell retention remains extremely challenging. Given that many hypoxic signals are transitory and that the therapeutic administration of MSCs is typically into tissues...
Daniel C Zielinski et al.
Nature communications, 6, 7101-7101 (2015-06-10)
Drug side effects cause a significant clinical and economic burden. However, mechanisms of drug action underlying side effect pathogenesis remain largely unknown. Here, we integrate pharmacogenomic and clinical data with a human metabolic network and find that non-pharmacokinetic metabolic pathways...

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service